title: [Editorial commentary: Hepatitis C].
authors.affiliation: I. Belgyógyászati Klinika, Pécsi Tudományegyetem, Klinikai Központ, Általános Orvostudományi Kar Pécs.
authors.forename: Alajos
authors.initials: A
authors.lastname: Pár
mesh_terms: D000998:Antiviral Agents / Q000191:economics / Q000627:therapeutic use*; D003226:Congresses as Topic; D003362:Cost-Benefit Analysis; D004359:Drug Therapy, Combination; D016174:Hepacivirus / Q000302:isolation & purification*; D006526:Hepatitis C / Q000150:complications / Q000175:diagnosis / Q000188:drug therapy* / Q000191:economics / Q000473:pathology; D006801:Humans; D006814:Hungary; D007372:Interferons / Q000627:therapeutic use; D008103:Liver Cirrhosis / Q000517:prevention & control / Q000821:virology*; D011480:Protease Inhibitors / Q000627:therapeutic use; D058028:Research Report; D012254:Ribavirin / Q000627:therapeutic use
chemical_list: D000998:Antiviral Agents; D011480:Protease Inhibitors; D012254:Ribavirin; D007372:Interferons